Streetbeat News

Analyst Ratings

AAPL

INTU

MA

PYPL

V

PayPal Holdings, Inc (PYPL) has appointed Alex Chriss, from Intuit Inc (INTU), as its new CEO, effective from September 27, 2023. Analysts from Mizuho and KBW have reiterated their Buy and Outperform ratings on PayPal, with price targets of $92.00 and $90.00 respectively. The new CEO will face challenges such as changing the narrative around PayPal's share loss to Apple Inc's (AAPL) Apple Pay and deciding on the potential merger of PayPal and Venmo brands.

Portfolio Pulse from Anusuya Lahiri

August 15, 2023 | 6:13 pm

URBN

Telsey Advisory Group analyst Dana Telsey has reiterated an Outperform rating on Urban Outfitters, Inc (NASDAQ:URBN), raising the price target to $41 from $35. The analyst expects a sales surge, margin upswing, and healthy inventory position for URBN in 2Q23. The company plans to open a new highly automated omni-fulfillment facility in Kansas City, Kansas, during the back half of FY24 and a new rental fulfillment facility in Missouri by the end of FY24.

Portfolio Pulse from Nabaparna Bhattacharya

August 15, 2023 | 6:07 pm

CHK

SBOW

Analysts have lowered the price target for Chesapeake Energy Corp (CHK) following its announcement to sell its remaining Eagle Ford assets to SilverBow Resources Inc (SBOW) for $700 million. The analysts expect the company to use the proceeds for share repurchases or acquisitions. However, the deal is considered immaterial given the scale of CHK's other assets. The price of CHK shares has fallen by 1.8%.

Portfolio Pulse from Lekha Gupta

August 15, 2023 | 6:04 pm

XFOR

Zacks Small Cap Research has set a valuation of $4.50 for X4 Pharmaceuticals' shares.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 6:03 pm

BTAI

Mizuho analyst Graig Suvannavejh downgraded BioXcel Therapeutics, Inc. (NASDAQ:BTAI) to Neutral from Buy, lowering the price target to $4 from $40. The downgrade follows BioXcel's Q2 results, which showed a net loss of $53.5 million. The analyst also pushed out the potential launch of BioXcel's drug, Igalmi, from 2025 to 2029, due to the assumption that the FDA will require a second Phase 3 study. Truist Securities analyst Robyn Karnauskas also lowered the price target for BioXcel to $31 from $71.

Portfolio Pulse from Nabaparna Bhattacharya

August 15, 2023 | 6:02 pm

SBOW

In the last quarter, SilverBow Resources (NYSE:SBOW) received 3 bullish and 1 somewhat bullish ratings from analysts. The company's average 12-month price target has increased by 12.71% from the previous average, now standing at $51.0 with a high of $59.00 and a low of $39.00.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 6:00 pm

NBTB

Analysts have provided ratings for NBT Bancorp (NASDAQ:NBTB) in the last quarter, with 3 somewhat bullish and 1 indifferent. The company has an average 12-month price target of $38.75, a decrease of 6.24% from the previous average price target of $41.33.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 6:00 pm

BILL

BILL Holdings (NYSE:BILL) has received a mix of bullish and indifferent analyst ratings over the last quarter, with no bearish ratings. The company's average price target has increased by 27.54% over the past month, currently standing at $142.71, with a high of $200.00 and a low of $105.00.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 6:00 pm

ICCM

In the last quarter, Icecure Medical (NASDAQ:ICCM) received five bullish analyst ratings with an average price target of $3.2, implying an upside from the current price of $0.9862. This average has decreased by 24.71% from the previous average price target of $4.25.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 6:00 pm

EOG

EOG Resources's (NYSE:EOG) short percent of float has risen 6.62% since its last report, with 8.45 million shares sold short, which is 1.45% of all regular shares available for trading. It would take traders 3.18 days to cover their short positions on average. An increase in short interest can signal that investors have become more bearish. EOG Resources's peer group average for short interest as a percentage of float is 6.14%, which means the company has less short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 6:00 pm